EUDAMED

The EU Commission has recently announced that the transition period for completing and implementing EUDAMED has been extended again. The previous target for full functionality was the second quarter of 2024. The new target date for this is now the second quarter of 2027.
Image of the EU flag - This image is used by Patient Guard to show their EU medical device and IVD consultancy services.
Facebook
X
LinkedIn

Introduction

EUDAMED

The EU Commission has recently announced that the transition period for completing and implementing EUDAMED has been extended again. The previous target for full functionality was the second quarter of 2024. The new target date for this is now the second quarter of 2027.

EUDAMED will consist of 6 interconnected modules with a public website:

  • Actors Registration
  • UDI/Devices Registration
  • Notified Bodies and Certificates
  • Clinical Investigations and Performance Studies
  • Vigilance and Post-Market Surveillance
  • Market Surveillance
  • EUDAMED Public (website)

EUDAMED is not yet mandatory nor required at this stage but some modules are already available and can be used voluntarily. The three modules currently in operation are; Actor Registration, UDI/Device Registration and Notified Bodies and Certificates. The remaining modules are still currently under development and will be released when EUDAMED is declared fully operational.

The proposed timelines for mandatory use of all modules are as follows:

EUDAMED (time line)

EUDAMED

Once all modules are complete an independent audit of these will be planned and should take place in the fourth quarter of 2026. This will be followed by an official EU report then a six month transition period.

Why the delay?

Full functionality of EUDAMED was originally planned for May 2020. Extensions have been included to allow more development time for the modules and a staggered release introduced. The second release date was planned for the end of 2023 but again, postponement was required due to some modules not being developed, specifically the Clinical Investigations and Performance Studies module. The new timelines shown above may not be met due to the complexity of the modules  and further delays are possible.

There are currently 40 Notified Bodies designated for regulation EU MDR 2017/745 in the EU. These NBs are responsible for auditing and issuing certificates for medical devices outside of Class I. Due to this relatively small number of approved Notified Bodies there are considerable delays in the re-certification of medical devices.

So what does this mean?

The extension to the regulations and EUDAMED database full release is not necessarily a negative impact for medical device manufacturers. This delay allows more time for adaption to the EU MDR 2017/745 and registration with the EUDAMED database. However, Patient Guard strongly recommend that manufacturers of medical devices register on EUDAMED and start to use any modules currently functional.

Current status of the European Commission on EUDAMED and functional modules

The following information is interpreted from the European Commission, Public Health website.

The three modules currently live are Actor Registration, UDI/Device Registration and Notified Bodies and Certificates.

The EU states that:

“The Commission is not in a position to require the use of Actor Registration module until EUDAMED is fully functional according to the Medial Device Regulation.”

“The European Commission is not in a position to require the use of the UDI/Devices registration module until EUDAMED is fully functional according to the Medical Device Regulation”.

“The European Commission is not in a position to require the use of the NBs & Certificates module until EUDAMED is fully functional according to the Medical Device Regulation”.

However;

Actor Registration: Every economic operator (EU and non-EU manufacturers, authorised representatives, system/procedure pack producers and importers) has to register as an actor in EUDAMED and provide the required information.

The required information is as follows:

Declaration on information security responsibilities
All actors must upload a signed declaration on information security responsibilities.

Mandate summary document
To register in EUDAMED, the non-EU manufacturers must have an active authorised representative and submit with the registration a mandate summary document.

UDI/Devices registration: Manufacturers can enter UDI/Device information in the EUDAMED system voluntarily.

Notified Bodies and Certificates module: NBs can register certificates and Summaries of Safety and Clinical Performance (SSCP) only on voluntary basis if all of the parties referenced in the certificates are first registered, also on a voluntary basis, in this database.

How can Patient Guard help?

Keep up to date with the latest regulatory news and updates by singing up to our news letter below, or contact us to see how using our medical device regulatory and quality assurance services can make your compliance journey easier. 

Resources

Most Popular

Cosmetics Regulations

Cosmetics Regulations are in place to ensure the safety, quality, and efficacy of products used on the skin, hair, and body. Regulations prevent the inclusion of harmful ingredients, protect consumers from potential health risks, and ensure accurate labeling and claims.

Read More »

October 2024 News Letter

Welcome to out October 2024 news letter, here we share the latest medical device regulatory news from the EU, UK and the USA as well as updated or new medical device standards that have been issued.

Read More »

UK Responsible Person (UKRP) – Medical Devices

The UKRP must provide written evidence that they have the manufacturer’s authority to act as their UK Responsible Person. Importers and distributors are not required to appoint a UK Responsible Person.

The UKRP acts on behalf of the non-UK manufacturer to carry out specified tasks in relation to the manufacturer’s obligations. As noted above, this includes registering the manufacturer’s devices with the MHRA before the devices can be placed on the UK market.

Read More »

The Biological Evaluation of Medical Devices

In healthcare, ensuring the safety and efficacy of medical devices is paramount. Patients rely on these devices for diagnosis, treatment, and improved quality of life.  Biological evaluation plays a pivotal role in determining the biological safety of these devices. Governed by international standards, most notably the ISO 10993 series, biological evaluation involves a thorough assessment of a device’s interaction with living tissues. This blog delves into the importance of biological evaluation, highlighting the critical biological endpoints outlined in ISO 10993, the significance of a robust biological evaluation plan, and the crucial role of qualified experts in this process.

Read More »
patient guard
Patient Guard

Sign up to our newsletter

Be the first to hear industry news and how Patient Guard can help you.

Do you need support with Medical Device or IVD compliance?

We can help you!